Abstract
We report twin neonates who were born prematurely at 32 weeks of gestation to a mother with human immunodeficiency virus infection. One of the twins developed complete heart block and dilated cardiomyopathy related to lopinavir/ritonavir therapy, a boosted protease-inhibitor agent, while the other twin developed mild bradycardia. We recommend caution in the use of lopinavir/ritonavir in the immediate neonatal period.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1127-1129 |
| Number of pages | 3 |
| Journal | Pediatric Infectious Disease Journal |
| Volume | 28 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 2009 |
Keywords
- Antiretroviral therapy
- Heart block
- Lopinavir/ritonavir
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Microbiology (medical)
- Infectious Diseases